Company: INVUP
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022223
Chunk: 1

Company: Investview, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 1
---
 product sales 
     1,029,673  
     -  
     1,029,673 
  
    Other revenue 
     32,598  
     -  
     32,598 
  
    Total revenue, net 
    $9,052,608  
    $11,742,881  
    $(2,690,273)

Total
revenue, net, decreased $2,690,273, or 23%, from $11,742,881 for the three months ended September 30, 2024, to $9,052,608 for the three
months ended September 30, 2025. The reduction in total revenue, net, can be attributed to a $4.1 million contraction in our membership
revenue, partially offset by an increase of $356 thousand and $1.0 million in mining revenue and our health and wellness product sales,
respectively. The $4.1 million (37%) decrease in membership revenue was due to the global macroeconomic downturn as individuals re-evaluated
their spending priorities, lifestyle habits, and engagement preferences, causing a slowdown in direct sales and home-based businesses.
This decrease was offset by the $356 thousand or 63% increase in mining revenue, a direct result of an increase in the price of Bitcoin,
partially offset by an increase in Bitcoin Network Difficulty and a $1.0 million increase in health and wellness product sales that arose
from our October 2024 acquisition of the business and assets of Renu Laboratories, Inc.

Operating
Costs and Expenses

    Three Months Ended September 30,  
    Increase 

    2025  
    2024  
    (Decrease) 

    (unaudited)  
    (unaudited)  

    Cost of sales and service 
    $2,153,524  
    $1,257,569  
    $895,955 
  
    Commissions 
     4,008,062  
     6,270,310  
     (2,262,248)
  
    Selling and marketing 
     356,556  
     16,751  
     339,805 
  
    Salary and related 
     1,773,323  
     1,471,649  
     301,674 
  
    Professional fees 
     536,090  
     416